1. Volume 140, Issue 7, Pages 1970-1979.e3 (June 2011)
Noninvasive Tests for Fibrosis and Liver Stiffness Predict 5-Year Outcomes of Patients With Chronic Hepatitis C 
Julien Vergniol, Juliette Foucher, Eric Terrebonne, Pierre–Henri Bernard, Brigitte le Bail, Wassil Merrouche, Patrice Couzigou, Victor de Ledinghen 
Gastroenterology 
Volume 140, Issue 7, Pages e3 (June 2011)
DOI: /j.gastro
Copyright © 2011 AGA Institute Terms and Conditions

2. Figure 1 Chart-flow of the study population.
Gastroenterology  , e3DOI: ( /j.gastro )
Copyright © 2011 AGA Institute Terms and Conditions

3. Figure 2
Overall survival probability according to liver stiffness, biomarkers, and liver biopsy. (A) Overall survival according to published cut-offs for the diagnosis of severe fibrosis or cirrhosis. (B) Overall survival according to different cut-offs of liver stiffness (kPa). Overall survival (95% confidence interval) using liver stiffness: ≤9.5 kPa: 96% (94%–98%); >9.5 kPa: 77% (72%–82%); >20 kPa: 66% (61%–71%); >30 kPa: 57% (50%–64%); >40 kPa: 47% (37%–57%); >50 kPa: 42% (29%–55%). (C) Overall survival according to different cut-offs of FibroTest. Overall survival (95% confidence interval) using FibroTest: ≤0.75: 97% (96%–98%); >0.75 and ≤0.80: 87% (78%–95%); >0.80 and ≤0.85: 84% (75%–94%); >0.85 and ≤0.90: 75% (61%–90%); >0.90 and ≤0.95: 69% (54%–84%); >0.95 to 1: 0% (0%–22%).
Gastroenterology  , e3DOI: ( /j.gastro )
Copyright © 2011 AGA Institute Terms and Conditions